4.6 Article

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Prevalence and sort of pharmacokinetic drug-drug interactions in hospitalized psychiatric patients

Gudrun Hefner et al.

JOURNAL OF NEURAL TRANSMISSION (2020)

Article Health Policy & Services

Long-Term Use of Benzodiazepines and Nonbenzodiazepine Hypnotics, 1999-2014

Christopher N. Kaufmann et al.

PSYCHIATRIC SERVICES (2018)

Review Medicine, General & Internal

The appropriate use of proton-pump inhibitors

Vincenzo Savarino et al.

MINERVA MEDICA (2018)

Review Pharmacology & Pharmacy

The risks of long-term use of proton pump inhibitors: a critical review

Megan Jaynes et al.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)

Review Medicine, General & Internal

Anticholinergic medication for antipsychotic-induced tardive dyskinesia

Hanna Bergman et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Review Gastroenterology & Hepatology

Proton-pump inhibitors: understanding the complications and risks

Peter Malfertheiner et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Review Geriatrics & Gerontology

What is polypharmacy? A systematic review of definitions

Nashwa Masnoon et al.

BMC GERIATRICS (2017)

Review Psychiatry

Pharmacotherapy for mental health problems in people with intellectual disability

Na Young Ji et al.

CURRENT OPINION IN PSYCHIATRY (2016)

Review Pharmacology & Pharmacy

Psychopharmacological interventions in autism spectrum disorder

Robert E. Accordino et al.

EXPERT OPINION ON PHARMACOTHERAPY (2016)

Article Medicine, General & Internal

Analysis of drug use in institutionalized individuals with intellectual disability and tube feeding

Elke Joos et al.

ACTA CLINICA BELGICA (2016)

Review Psychology, Educational

Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems

Arlette Scheifes et al.

JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2016)

Review Medicine, General & Internal

Reducing Inappropriate Polypharmacy The Process of Deprescribing

Ian A. Scott et al.

JAMA INTERNAL MEDICINE (2015)

Review Pharmacology & Pharmacy

Clinical consequences of polypharmacy in elderly

Robert L. Maher et al.

EXPERT OPINION ON DRUG SAFETY (2014)

Article Health Policy & Services

Psychotropic Prescribing for Persons With Intellectual Disabilities and Other Psychiatric Disorders

Gail A. Edelsohn et al.

PSYCHIATRIC SERVICES (2014)

Article Education, Special

Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability

Syed Imran Haider et al.

RESEARCH IN DEVELOPMENTAL DISABILITIES (2014)

Article Pharmacology & Pharmacy

Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria

Chirn-Bin Chang et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)

Article Education, Special

Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study

M. Amore et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2011)

Review Clinical Neurology

PHARMACOTHERAPY OF DISRUPTIVE BEHAVIOR IN MENTALLY RETARDED SUBJECTS: A REVIEW OF THE CURRENT LITERATURE

Frank Haessler et al.

DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2010)

Article Public, Environmental & Occupational Health

Adverse drug events in the outpatient setting: an 11-year national analysis

Florence T. Bourgeois et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)

Article Education, Special

Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities

S. L. Ruedrich et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2008)

Article Psychiatry

A review of empirical evidence of somatic treatment options for the MI/DD population

Thaddeus P. Ulzen et al.

PSYCHIATRIC QUARTERLY (2008)

Article Pharmacology & Pharmacy

Dyspepsia in chronic psychiatric patients

EJ Mookhoek et al.

PHARMACOPSYCHIATRY (2005)

Article Pharmacology & Pharmacy

Autism: a target of pharmacotherapies?

R Gerlai et al.

DRUG DISCOVERY TODAY (2004)

Review Clinical Neurology

Self-injurious behavior and the efficacy of Naltrexone treatment: A quantitative synthesis

FJ Symons et al.

MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2004)